EcoDrugPlus

Adenosine A1 Receptor

Ensembl ID : ENSDORG00000027122
Gene Symbol: ADORA1
4 Cross references
275 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSDORG00000026806
Gene Symbol: ADORA2B
4 Cross references
201 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSDORG00000004804
Gene Symbol: ADA
3 Cross references
219 Possible Orthologues:

Adenosine Receptor A3-Like

Ensembl ID : ENSDORG00000024247
Gene Symbol: LOC105991955
4 Cross references
273 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSDORG00000016587
Gene Symbol: ADRM1
3 Cross references
261 Possible Orthologues:

Adrenergic Receptor, Alpha 1b

Ensembl ID : ENSDORG00000005707
Gene Symbol: ADRA1B
1 Cross references
265 Possible Orthologues:

Adrenergic Receptor, Beta 3

Ensembl ID : ENSDORG00000010152
Gene Symbol: ADRB3
1 Cross references
218 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSDORG00000005782
Gene Symbol: ADRA1A
3 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSDORG00000009804
Gene Symbol: ADRA1D
4 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSDORG00000025033
Gene Symbol: ADRA2A
3 Cross references
227 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSDORG00000023944
Gene Symbol: ADRA2B
3 Cross references
222 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSDORG00000029260
Gene Symbol: ADRA2C
3 Cross references
227 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).